ATE70561T1 - Verfahren zur kultur des virus der rhinotracheitis des truthahnes und daraus hergestelltes vakzin. - Google Patents

Verfahren zur kultur des virus der rhinotracheitis des truthahnes und daraus hergestelltes vakzin.

Info

Publication number
ATE70561T1
ATE70561T1 AT87460013T AT87460013T ATE70561T1 AT E70561 T1 ATE70561 T1 AT E70561T1 AT 87460013 T AT87460013 T AT 87460013T AT 87460013 T AT87460013 T AT 87460013T AT E70561 T1 ATE70561 T1 AT E70561T1
Authority
AT
Austria
Prior art keywords
culture
rhinotracheitis virus
virus
production
vaccine prepared
Prior art date
Application number
AT87460013T
Other languages
English (en)
Inventor
Patrick Giraud
Georges Bennejean
Michele Guittet
Didier Toquin
Original Assignee
Ministere De L Agriculture Dir
Rhone Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ministere De L Agriculture Dir, Rhone Merieux filed Critical Ministere De L Agriculture Dir
Application granted granted Critical
Publication of ATE70561T1 publication Critical patent/ATE70561T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18361—Methods of inactivation or attenuation
    • C12N2760/18364—Methods of inactivation or attenuation by serial passage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT87460013T 1986-08-18 1987-07-16 Verfahren zur kultur des virus der rhinotracheitis des truthahnes und daraus hergestelltes vakzin. ATE70561T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8611872A FR2602791B1 (fr) 1986-08-18 1986-08-18 Procede de culture du virus de la rhinotracheite infectieuse de la dinde, et vaccin prepare a partir du virus ainsi obtenu
EP87460013A EP0263048B1 (de) 1986-08-18 1987-07-16 Verfahren zur Kultur des Virus der Rhinotracheitis des Truthahnes und daraus hergestelltes Vakzin

Publications (1)

Publication Number Publication Date
ATE70561T1 true ATE70561T1 (de) 1992-01-15

Family

ID=9338390

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87460013T ATE70561T1 (de) 1986-08-18 1987-07-16 Verfahren zur kultur des virus der rhinotracheitis des truthahnes und daraus hergestelltes vakzin.

Country Status (7)

Country Link
US (1) US4810493A (de)
EP (1) EP0263048B1 (de)
AT (1) ATE70561T1 (de)
CA (1) CA1277270C (de)
DE (1) DE3775321D1 (de)
ES (1) ES2038689T3 (de)
FR (1) FR2602791B1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0292210B1 (de) * 1987-05-21 1993-03-10 Know-How Licensors Limited Abgeschwächtes Virus und Impfstoffe davon zur Verwendung gegen Infektionen bei Geflügel, verursacht durch Truthahn-Rhinotracheitis-Virus
US6080570A (en) * 1991-08-26 2000-06-27 Boehringer Ingelheim Vetmedica, Inc. Method of producing a vaccine for Swine Infertility and Respiratory Syndrome
US6982160B2 (en) 1991-08-26 2006-01-03 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions that include SIRS virus
KR0138092B1 (ko) * 1991-08-26 1998-04-30 제임스 씨. 데세사레 미확인(Mystery) 돼지 질병 관련 바이러스제
US5846805A (en) 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
EP0839912A1 (de) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Ansteckende Klone von RNA-Viren und darauf basierende Impfstoffe und diagnostisches Verfahren
US20040224327A1 (en) * 1996-10-30 2004-11-11 Meulenberg Johanna Jacoba Maria Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
EP1157121B1 (de) 1999-03-08 2013-04-24 Boehringer Ingelheim Vetmedica GmbH Prrsv replikon
ES2388909T3 (es) 1999-04-22 2012-10-19 The United States Of America, As Represented Bythe Secretary Of Agriculture Vacuna contra el virus del síndrome respiratorio y reproductivo porcino basada en aislado JA-142 aislada
FR2801607B1 (fr) * 1999-11-26 2001-12-28 Merial Sas Pneumovirus du canard et vaccins correspondants
SG153829A1 (en) 2004-06-18 2009-07-29 Univ Minnesota Identifying virally infected and vaccinated organisms
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
PT2369001T (pt) 2005-06-24 2016-10-25 Univ Minnesota Vírus srrp, clones infecciosos, os seus mutantes e processos de utilização
KR101653177B1 (ko) * 2008-08-25 2016-09-01 베링거잉겔하임베트메디카인코퍼레이티드 고병원성 돼지 생식기 및 호흡기 증후군(ｈｐ ｐｒｒｓ)에 대한 백신
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
EP2675475B1 (de) 2011-02-17 2015-07-01 Boehringer Ingelheim Vetmedica GmbH Neuer europäischer prrsv-stamm
SG192821A1 (en) 2011-02-17 2013-09-30 Boehringer Ingelheim Vetmed Commercial scale process for production of prrsv
EP2737059A1 (de) 2011-07-29 2014-06-04 Boehringer Ingelheim Vetmedica GmbH Neuartiges prrs-virus zur induktion von interferon des typs i in empfindlichen zellen
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
US9579373B2 (en) 2013-03-15 2017-02-28 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215107A (en) * 1978-12-29 1980-07-29 Merck & Co., Inc. Parainfluenza virus vaccine and its preparation
PT72077B (en) * 1979-11-30 1981-09-29 Gist Brocades Nv Infectious bronchitis vaccines for poultry and process forthe preparation of such vaccines
EP0073856A1 (de) * 1981-08-28 1983-03-16 Gist-Brocades N.V. Impfstoff gegen ansteckende Bronchitis bei Geflügel, kombinierte Impfstoffe gegen ansteckende Bronchitis, Verfahren zu deren Herstellung, Verfahren zur Vorbeugung der ansteckenden Bronchitis und Virenstamm der ansteckenden Bronchitis

Also Published As

Publication number Publication date
US4810493A (en) 1989-03-07
FR2602791A1 (fr) 1988-02-19
DE3775321D1 (de) 1992-01-30
EP0263048A1 (de) 1988-04-06
EP0263048B1 (de) 1991-12-18
ES2038689T3 (es) 1993-08-01
CA1277270C (fr) 1990-12-04
FR2602791B1 (fr) 1988-11-10

Similar Documents

Publication Publication Date Title
ATE70561T1 (de) Verfahren zur kultur des virus der rhinotracheitis des truthahnes und daraus hergestelltes vakzin.
KR0156732B1 (ko) 연속 셀 라인에서의 ibdv 생성
DE60017234D1 (de) Vakzinproduktion
ATE482267T1 (de) Tierzellen und verfahren für die replikation von influenza viren
Pay et al. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process
ATE205536T1 (de) Mutanten von hepatitis a virus stamm hm-175 zur verwendung als hepatitis a virus impfstoffe
ES553758A0 (es) Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia.
DE2962920D1 (en) Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it
ATA292889A (de) Verfahren zur herstellung von fsme-virus-antigen
ES2052883T3 (es) Cultivo de celulas de riñon de cerdo y su uso en la produccion de vacunas.
ATE14984T1 (de) Verfahren zur herstellung eines biochemischen vakzins gegen salmonellenfieber.
ATE4441T1 (de) Verfahren zur herstellung von influenza-avirusimpfst[mmen, virusimpfstamm und diesen enthaltender impfstoff.
PL341724A1 (en) Mutated newcastle disease virus (ndv) and method of obtaining same, live or inactivated vaccine containing same and method of obtaining such vaccine
JPH0571226B2 (de)
RU98116217A (ru) Способ получения белка с использованием трансляционной системы митохондрий
WO1997027742B1 (en) Method of protein production using mitochondrial translation system
SE8700466L (sv) Vacciner mor melanom
GB1065875A (en) Measles vaccine attenuated through avian choric-allantoic membrane
RU2022132198A (ru) Живой аттенуированный штамм вируса желтой лихорадки, адаптированный к росту в клетках vero, и вакцинная композиция, содержащая его
RU2020136260A (ru) Живой аттенуированный штамм вируса желтой лихорадки, адаптированный к росту в клетках vero, и вакцинная композиция, содержащая его
BG61384B1 (bg) метод за получаване на жива атенуирана клетъчно-културална ваксина против псевдочума по птиците
Nishibe et al. Induction of SMON-type virus from avian infectious laryngotracheitis virus
HUT37353A (en) Process for producing vaccine for treating infective laryngitis and trachitis of fowls
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
KR920009980A (ko) 신균주 nd dsb hp주 및 이로부터 닭뉴캣슬병 내열성 백신을 제조하는 방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties